Sponsored Videos

Evolving to Meet the Future Needs of Customers: Interview with Adare CEO Tom Sellig

CEO Tom Sellig highlights Adare’s integrated end-to-end CDMO services, emphasizing our oral dose capabilities and small molecule expertise.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

In this video from Pharmaceutical Technology, CEO Tom Sellig highlights Adare’s integrated end-to-end CDMO services, emphasizing our oral dose capabilities and small molecule expertise. He discusses recent and planned expansions, including packaging, high potency, and controlled substances offerings, along with a new nitrosamine mitigation offering.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters